Published in Genetics and Environmental Business Week, February 22nd, 2007
"Our ability to couple our microarray-based ChIP-DSL platform for genome wide promoter-transcription factor detection with our high throughput antibody production capabilities offers our customers a complete and unique package for transcription regulation assays. This systems-based approach to understanding transcriptional regulation, epigenetic modifications and DNA methylation should provide new and significant...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.